William Vollmer to Cost-Benefit Analysis
This is a "connection" page, showing publications William Vollmer has written about Cost-Benefit Analysis.
Connection Strength
0.320
-
Improving Adherence to Cardiovascular Therapies: An Economic Evaluation of a Randomized Pragmatic Trial. Value Health. 2016 Mar-Apr; 19(2):176-84.
Score: 0.123
-
Design of the Prevention of Adult Caries Study (PACS): a randomized clinical trial assessing the effect of a chlorhexidine dental coating for the prevention of adult caries. BMC Oral Health. 2010 Oct 05; 10:23.
Score: 0.085
-
Costs and Cost-Effectiveness of Implementing a Digital Diabetes Prevention Program in a Large, Integrated Health System. Perm J. 2022 09 14; 26(3):74-82.
Score: 0.048
-
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
Score: 0.027
-
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study. Eur Respir J. 2013 Mar; 41(3):548-55.
Score: 0.024
-
The pharmacoepidemiology of COPD: recent advances and methodological discussion. Eur Respir J Suppl. 2003 Sep; 43:1s-44s.
Score: 0.013